252 related articles for article (PubMed ID: 26986110)
1. The Association of Ursodeoxycholic Acid Use With Colorectal Cancer Risk: A Nationwide Cohort Study.
Huang WK; Hsu HC; Liu JR; Yang TS; Chen JS; Chang JW; Lin YC; Yu KH; Kuo CF; See LC
Medicine (Baltimore); 2016 Mar; 95(11):e2980. PubMed ID: 26986110
[TBL] [Abstract][Full Text] [Related]
2. Association of gout and colorectal cancer in Taiwan: a nationwide population-based cohort study.
Chuang JP; Lee JC; Leu TH; Hidajah AC; Chang YH; Li CY
BMJ Open; 2019 Oct; 9(10):e028892. PubMed ID: 31601586
[TBL] [Abstract][Full Text] [Related]
3. High dose ursodeoxycholic acid in primary sclerosing cholangitis does not prevent colorectal neoplasia.
Lindström L; Boberg KM; Wikman O; Friis-Liby I; Hultcrantz R; Prytz H; Sandberg-Gertzén H; Sangfelt P; Rydning A; Folvik G; Gangsøy-Kristiansen M; Danielsson A; Bergquist A
Aliment Pharmacol Ther; 2012 Feb; 35(4):451-7. PubMed ID: 22221173
[TBL] [Abstract][Full Text] [Related]
4. Association between irritable bowel syndrome and colorectal cancer: a nationwide population-based study.
Hsiao CW; Huang WY; Ke TW; Muo CH; Chen WT; Sung FC; Kao CH
Eur J Intern Med; 2014 Jan; 25(1):82-6. PubMed ID: 24268837
[TBL] [Abstract][Full Text] [Related]
5. Preventive administration of UDCA after liver transplantation for primary biliary cirrhosis is associated with a lower risk of disease recurrence.
Bosch A; Dumortier J; Maucort-Boulch D; Scoazec JY; Wendum D; Conti F; Morard I; Rubbia-Brandt L; Terris B; Radenne S; Abenavoli L; Poupon R; Chazouillères O; Calmus Y; Boillot O; Giostra E; Corpechot C
J Hepatol; 2015 Dec; 63(6):1449-58. PubMed ID: 26282232
[TBL] [Abstract][Full Text] [Related]
6. Ursodiol use is possibly associated with lower incidence of hepatocellular carcinoma in hepatitis C virus-associated liver cirrhosis.
Tarao K; Fujiyama S; Ohkawa S; Miyakawa K; Tamai S; Hirokawa S; Masaki T; Tanaka K
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):164-9. PubMed ID: 15668491
[TBL] [Abstract][Full Text] [Related]
7. Helicobacter pylori infection and the risk of colorectal cancer: a nationwide population-based cohort study.
Liu IL; Tsai CH; Hsu CH; Hu JM; Chen YC; Tian YF; You SL; Chen CY; Hsiao CW; Lin CY; Chou YC; Sun CA
QJM; 2019 Oct; 112(10):787-792. PubMed ID: 31250012
[TBL] [Abstract][Full Text] [Related]
8. In PSC with colitis treated with UDCA, most colonic carcinomas develop in the first years after the start of treatment.
Rudolph G; Gotthardt DN; Kloeters-Plachky P; Kulaksiz H; Schirmacher P; Stiehl A
Dig Dis Sci; 2011 Dec; 56(12):3624-30. PubMed ID: 21656181
[TBL] [Abstract][Full Text] [Related]
9. The association between low-dose aspirin use and the incidence of colorectal cancer: a nationwide cohort study.
Huang WK; Chiou MJ; Yu KH; Lin YC; Yang TS; Chen JS; Kuo CF; See LC
Aliment Pharmacol Ther; 2013 Aug; 38(4):432-9. PubMed ID: 23799975
[TBL] [Abstract][Full Text] [Related]
10. Risk of suicide attempts among colorectal cancer patients: A nationwide population-based matched cohort study.
Sun LM; Lin CL; Hsu CY; Kao CH
Psychooncology; 2018 Dec; 27(12):2794-2801. PubMed ID: 30225911
[TBL] [Abstract][Full Text] [Related]
11. Long-term ursodeoxycholic acid therapy is associated with reduced risk of biliary pain and acute cholecystitis in patients with gallbladder stones: a cohort analysis.
Tomida S; Abei M; Yamaguchi T; Matsuzaki Y; Shoda J; Tanaka N; Osuga T
Hepatology; 1999 Jul; 30(1):6-13. PubMed ID: 10385632
[TBL] [Abstract][Full Text] [Related]
12. Use of an α-Glucosidase Inhibitor and the Risk of Colorectal Cancer in Patients With Diabetes: A Nationwide, Population-Based Cohort Study.
Tseng YH; Tsan YT; Chan WC; Sheu WH; Chen PC
Diabetes Care; 2015 Nov; 38(11):2068-74. PubMed ID: 26307605
[TBL] [Abstract][Full Text] [Related]
13. Risk of colorectal cancer in chronic kidney disease: a matched cohort study based on administrative data.
Wu MY; Chang TC; Chao TY; Huang MT; Lin HW
Ann Surg Oncol; 2013 Nov; 20(12):3885-91. PubMed ID: 23807660
[TBL] [Abstract][Full Text] [Related]
14. Association between gastroesophageal reflux disease and colorectal cancer risk: a population-based cohort study.
Hu JM; Wu JJ; Hsu CH; Chen YC; Tian YF; Chang PK; Chen CY; Chou YC; Sun CA
Int J Colorectal Dis; 2021 Nov; 36(11):2411-2418. PubMed ID: 33861389
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of ursodeoxycholic acid on COVID-19 in patients with chronic liver disease.
Li Y; Zhu N; Cui X; Lin Y; Li X
Front Cell Infect Microbiol; 2023; 13():1178590. PubMed ID: 37207192
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of Ursodeoxycholic Acid in the Prevention of Cholelithiasis After Sleeve Gastrectomy.
Coupaye M; Calabrese D; Sami O; Siauve N; Ledoux S
Obes Surg; 2019 Aug; 29(8):2464-2469. PubMed ID: 30945151
[TBL] [Abstract][Full Text] [Related]
17. Increased incidence of colorectal cancer with obstructive sleep apnea: a nationwide population-based cohort study.
Chen CY; Hu JM; Shen CJ; Chou YC; Tian YF; Chen YC; You SL; Hung CF; Lin TC; Hsiao CW; Lin CY; Sun CA
Sleep Med; 2020 Feb; 66():15-20. PubMed ID: 31785565
[TBL] [Abstract][Full Text] [Related]
18. Risk of colorectal cancer in women with pelvic inflammatory disease: a matched cohort study.
Hsu MI; Lin HW
BJOG; 2014 Feb; 121(3):337-42. PubMed ID: 24131489
[TBL] [Abstract][Full Text] [Related]
19. Risk of mood disorders in patients with colorectal cancer.
Sun LM; Liang JA; Lin CL; Sun S; Kao CH
J Affect Disord; 2017 Aug; 218():59-65. PubMed ID: 28458117
[TBL] [Abstract][Full Text] [Related]
20. Ursodeoxycholic acid therapy and the risk of colorectal adenoma in patients with primary biliary cirrhosis: an observational study.
Serfaty L; De Leusse A; Rosmorduc O; Desaint B; Flejou JF; Chazouilleres O; Poupon RE; Poupon R
Hepatology; 2003 Jul; 38(1):203-9. PubMed ID: 12830003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
